FOLFOX4 and concomitant highly active antiretroviral therapy (HAART) in metastatic colorectal cancer (M-CRC) HIV-positive patients (pts): A GICAT experience

15046 Background: This study was performed to evaluate retrospectively the efficacy and tolerance of FOLFOX4 regimen, with concomitant HAART, in M-CRC HIV-positive pts. Methods: From February 2002 ...